Open Access

Life-threatening cardiac episode in a Polish patient carrying contiguous gene microdeletion of the TBX5 and the TBX3 genes

  • Katarzyna Iwanicka-Pronicka1, 2Email author,
  • Magdalena Socha3,
  • Maria Jędrzejowska1,
  • Małgorzata Krajewska-Walasek1 and
  • Aleksander Jamsheer3, 4
SpringerPlus20165:1638

https://doi.org/10.1186/s40064-016-3275-1

Received: 3 December 2015

Accepted: 8 September 2016

Published: 21 September 2016

Abstract

Holt–Oram syndrome (HOS) features radial ray hypoplasia, heart defect and cardiac conduction impairment. Ulnar-mammary syndrome (UMS) characterizes congenital defects of the ulnar side of the upper limbs, underdevelopment of apocrine glands including hypoplasia and the dysfunction of mammary glands, hypogonadism and obesity. Inheritance of both conditions is autosomal dominant, mutations or deletions are found in the TBX5 and TBX3 gene, respectively. The Polish patient presented short stature, obesity, congenital malformation of the radial and ulnar side of the upper limbs, heart block, hypogonadism and dysmorphic features. At the age of 13 years he lost consciousness developing respiratory insufficiency caused by bradycardia in the course of sudden atrioventricular third degree heart block requiring immediate implantation of pace maker-defibrillator device. Microdeletion of the 12q24.21 was identified using array CGH method. This region includes contiguous genes the TBX5, TBX3, and part of RBM19. The patient initially diagnosed as having HOS, was found to present the UMS features as well. Array CGH method should be applied in patients suspected of HOS or UMS, especially when sequencing of TBX5 or TBX3 genes fails to identify causative mutation.

Keywords

Microdeletion Array-CGH Holt–Oram syndrome Ulnar-mammary syndrome Heart block TBX5 gene TBX3 gene

Background

Holt–Oram syndrome (HOS, OMIM 142900) is a genetic condition characterized by radial ray hypoplasia and congenital heart defect often associated with progressive arrhythmias and dysmorphic features (Holt and Oram 1960; Harris and Osborne 1966). The syndrome is usually caused by point mutations or intragenic deletions of the TBX5 gene, however in rare cases it results from larger deletions encompassing the entire TBX5 coding sequence (Basson et al. 1997; Gruenauer-Kloevekorn and Froster 2003; Newbury-Ecob et al. 1996). Ulnar-mammary syndrome (UMS, OMIM 181450) is a congenital malformation syndrome characterized by the ulnar hypoplasia of the upper limbs, usually comprising absent or hypoplastic 5th and/or 4th fingers, absent or hypoplastic ulna, underdevelopment of the apocrine glands resulting in the dysfunction of the mammary and axillary glands, hypogonadism with genital anomalies and delayed puberty in males, obesity, absence of axillary hair and tooth abnormalities (Schinzel 1987; Pallister et al. 1976). UMS also referred to as Schinzel syndrome or Pallister ulnar-mammary syndrome can result from either point mutations or deletions of the TBX3 gene (Bamshad et al. 1997; Linden et al. 2009). Microdeletions of the 12q24.21 region comprising the two neighbouring TBX5 and TBX3 genes lead to the phenotype characterized by a combination of the clinical symptoms associated with both disorders (Borozdin et al. 2006; Alby et al. 2013; Bogarapu et al. 2014).

Case description

This boy was born at term, by Caesarean section due to foetal bradycardia. His birth weight was of 2700 g, length of 51 cm, and Apgar score of 2-2-2-7 points at 1, 3, 5, 15 min, respectively. The early psychomotor and intellectual development was normal and the boy attended public school. His parents, younger sister and two maternal half-siblings are healthy.

He was referred to our Institute at the age of 14 years due to dysmorphic features, congenital malformations of the upper limbs, heart block, and hypogonadism. The boy presented with short stature 145 cm (<3 pc), prominent truncal obesity 48 kg (25–50 pc), steatomastia, and hypoplastic, low set nipples. His neck was short with lower hairline and downsloping shoulders Fig. 1. The face was oval in shape with fat accumulation under the chin. Dysmorphic features included hypertelorism, epicanthal folds, slanting downwards palpebral fissures, long nose, long philtrum and small mouth with narrow upper lip set of the horseshoe shape. The ears were slightly protruding with thick lobes and recurvate helix. Anomalies in the oral cavity included high-arched palate and overlapping, crowded teeth. Additionally, he had small hypoplastic penis embedded in adipose tissue, right-sided cryptorchidism, underdeveloped, shawl scrotum containing a small left testicle.
Fig. 1

The patient’s silhouette. Rtg of the patient’s hands. Anterior and posterior palmar surface of the left hand of the patient

Skeletal malformations comprised hypoplasia of pectoral muscles, shortening of forearms, bilateral hypoplasia of radial side of the hands (with small, hypoplastic biphalangeal yet non-opposable thumbs), hypoplasia of thenar and hypothenar eminences and brachydactyly Fig. 1. Radiologic examination revealed 3-years delay in carpal ossification Fig. 1. Echocardiography revealed mitral valve regurgitation without any structural abnormalities. At age of 13 years the boy suddenly developed cardiac arrhythmia leading to unconsciousness and rapidly progressive lung oedema. He required mechanical ventilation. This episode was followed by the development of third degree heart block resulting in severe bradycardia about 47 beat per min and prolonged Q-T interval requiring implantation of endocavitary cardioverter defibrillator device.

Based on the phenotypic presentation and negative sequencing of the TBX5 gene, high-resolution array CGH method was applied. Heterozygous interstitial contiguous gene deletion of the TBX5 and TBX3 encompassing 1.79 Mb of the chromosome 12q24.21 region was revealed and subsequently confirmed by qPCR. The minimal genomic coordinates of the detected deletion were 114297717–116091603 according to hg19 database Fig. 2. Paternal origin of the deletion was excluded with the use of qPCR, while maternal DNA was unavailable for testing.
Fig. 2

Array CGH profile of chromosome 12. Red frame at the chromosome 12 (at the bottom of the picture) localised in the region 12q24.21 indicates the microdeletion of 1.79 Mb found in the Polish proband, encompassing the contignous genes: TBX5, TBX3, and part of the RBM19; the minimal genomic coordinates 12: 114297717–116091603—(hg19). Green frame shows the microdeletion of 2.2–2.3 Mb found in Borozdin’s Czech family: telomere end: 114,750,000–114,800,000; centromere end: 112,560,000–112,460,000). Blue and violet frames point the microdeletions of 2.44 and 2.6 Mb found in French patients of Alby 12: 113,084,817–115,681,244—(hg19) and 12: 113,197,408–113,736,198—(hg18). Orange frame displays the microdeletion of 2.6 Mb found in the Spanish boy presented by Bogarapu 12: 112,963,559–116,095,198—(hg19)

Discussion and evaluation

We describe a Polish proband presenting the overlapping phenotype of HOS and UMS, resulting from contiguous microdeletion comprising the TBX5, TBX3 and a part of RBM19 genes, located on chromosome 12q24.21. To date, similar molecular defects and clinical phenotypes have been described only in seven patients from four unrelated families. The size of the microdeletions varied among the patients, although our case carrying smaller than previously described changes presented the most severe, life-threatening cardiological symptoms and dysmorphia.

The first description of HOS and UMS overlap was provided by Borozdin et al. (2006), who presented a Czech family: the mother and her two daughters. A size of the microdeletion identified in those patients was delineated as 2.19 to 2.27 Mb, slightly larger than in our patient. Distinct dysmorphic features of those patients compared to our proband included hypertrichosis of the hands, back, and genital region, cleft between 4th and 5th fingers and congenital heart defect (VSD and ASD). The most serious medical problem described in one child from the Czech family involved subglottic laryngeal stenosis requiring long-term ventilation through laryngeal tube.

The next report of Alby et al. (2013) presented two unrelated French females and a foetus, all with contiguous deletions encompassing 2.6 and 2.44 Mb also involving the TBX5 and TBX3 genes. Both women manifested mild clinical features being a combination of both syndromes. One of them has additionally growth hormone deficiency, while her foetus presented with VSD and hypoplastic aorta.

The latest paper of Bogarapu et al. (2014) described a boy of Spanish origin, who presented with social impairment, speech and motor delay. Physically, the boy fulfilled combined diagnostic criteria of HOS and UMS. Array CGH study performed in this patient revealed the presence of two deletions: one 3.1 Mb in size encompassing TBX5, TBX3 and 17 other genes, and the second occurring at 12p13.33 and involving four genes. Since little is known about the function of the remaining haploinsufficient genes, one can hypothesize on their possible contribution to the development of the clinical and behavioural phenotype of this patient.

The RBM19 gene was found to be partially deleted in our proband. Literature data suggests the role of RBM19 in the proliferation, differentiation, and development of the intestinal epithelium (Lorenzen et al. 2005). Although the impact of the partial deletion of this gene on phenotype is unknown, one can assume the substantial effect on phenotype of RBM19 haploinsufficiency, as well as other noncoding and enhancing regions for distal genes affected by partial deletion, or microRNA fragments potentially existing in non-coding sequences of the region.

The co-occurrence of cardiac involvement is more characteristic for deletions of the TBX5 gene that code a transcriptional activation factor promoting heart development, especially cardiac primordial structures (Bruneau et al. 2001). However, a dysfunction of heart conduction system may also result from the TBX3 deletion (Hoogaars et al. 2007). Borozdin et al. (2006) suggested that the deletion of the TBX3 gene may probably enhance the severity of the cardiac phenotype caused by haploinsufficiency of the TBX5 gene. We believed that bradyarrhythmia observed in our patient is caused by TBX5 deletion, and is not enhanced by TBX3 rearrangement.

It was described that TBX5 and TBX3 evolutionary derive from the common ancestral gene, and each of them acquired a complementary role in the development of mammalian upper limb (Boehme and Shotar 1989). A diversity of symptoms encountered in patients with the deletion of the TBX5 and TBX3 genes reflects their versatile developmental role, involving the formation of heart, radial and ulnar side of forelimb, lungs, pharynx, thorax, body wall, and mature retina (Borozdin et al. 2006). It should be stressed that the clinical features of patients carrying the rearrangement result not only from the lack of the deleted genes, but also from other existed undetermined distal enhancer elements, or microRNAs as well.

Conclusions

The patient carrying a contiguous microdeletion of TBX5 and TBX3 genes displays features of Holt–Oram Syndrome (HOS) and ulnar-mammary syndrome (UMS). The most prominent symptoms observed in our case are progressive arrhythmia leading to heart failure accompanied by heart defect, bilateral upper limb malformation of the radial and ulnar side, short stature, obesity, hypogonadism causing delayed puberty, hypoplastic apocrine glands, teeth anomalies and dysmorphia. Such molecular defect may be detected using array CGH method. The size of the microdeletion encompassing the region of 12q24.21 does not strictly influence the severity of the phenotype. Polish patient presenting with the most severe clinical manifestation in reference to the previously described patients, carries the smallest molecular change. Numerous health complications seen in patients with haploinsufficiency of the TBX5 and TBX3 genes entail a multidisciplinary care. Critical heart complication in our case suggests need for thorough cardiological monitoring, because of risk for sudden heart insufficiency resulting from the progressive conduction impairment. Affected newborns showing respiration problems should be suspected of having subglottic laryngeal stenosis, thus they require immediate phoniatric management.

Abbreviations

HOS: 

Holt–Oram syndrome

UMS: 

ulnar-mammary syndrome = Schinzel syndrome or Pallister ulnar-mammary syndrome

aCGH: 

array comparative genomic hybridisation

Declarations

Authors’ contributions

KIP MKW MJ clinical diagnosis of the patient; KIP wrote the manuscript; AJ critically revised and corrected the manuscript, analysed results of genetic investigations; MS performed and analysed molecular studies. All authors read and approved the final manuscript.

Acknowledgements

The study was supported by a grant from the Polish National Science Centre (UMO-2011-03-D-NZ2-06136) to AJ.

Competing interests

The authors declare that they have no competing interests.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Medical Genetics, Children’s Memorial Health Institute
(2)
Department of Audiology and Phoniatrics, Children’s Memorial Health Institute
(3)
Department of Medical Genetics, Poznan University of Medical Sciences
(4)
NZOZ Center for Medical Genetics

References

  1. Alby C, Bessieres B, Bieth E, Attie-Bitach T, Fermont L, Citony I, Razavi F, Vekemans M, Escande F, Manouvrier S, Malan V, Amiel J (2013) Contiguous gene deletion of TBX5 and TBX3 leads to a variable phenotype with combined features of Holt–Oram and ulnar-mammary syndromes. Am J Med Genet A 161A(7):1797–1802. doi:https://doi.org/10.1002/ajmg.a.36054 View ArticlePubMedGoogle Scholar
  2. Bamshad M, Lin RC, Law DJ, Watkins WC, Krakowiak PA, Moore ME, Franceschini P, Lala R, Holmes LB, Gebuhr TC, Bruneau BG, Schinzel A, Seidman JG, Seidman CE, Jorde L (1997) Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nature Genet 16:311–315View ArticlePubMedGoogle Scholar
  3. Basson CT, Bachinsky DR, Lin RC (1997) Mutations in human TBX5 cause limb and cardiac malformation in Holt–Oram syndrome. Nature Genet 15:30–35View ArticlePubMedGoogle Scholar
  4. Boehme DH, Shotar AO (1989) A complex deformity of appendicular skeleton and shoulder with congenital hear t disease in three generations of a Jordanian family. Clin Genet 36:442–450View ArticlePubMedGoogle Scholar
  5. Bogarapu S, Bleyl SB, Calhoun A, Viskochil D, Saarel EV, Everitt MD, Frank DU (2014) Phenotype of a patient with contiguous deletion of TBX5 and TBX3: expanding the disease spectrum. Am J Med Genet A 164A(5):1304–1309. doi:https://doi.org/10.1002/ajmg.a.36447 View ArticlePubMedGoogle Scholar
  6. Borozdin W, Bravo-Ferrer Acosta AM, Seemanova E, Leipoldt M, Bamshad MJ, Unger S, Kohlhase J (2006) Contiguous hemizygous deletion of TBX5, TBX3, and RBM19 resulting in a combined phenotype of Holt–Oram and ulnar-mammary syndromes. Am J Med Genet 140A:1880–1886View ArticlePubMedGoogle Scholar
  7. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG (2001) A murine model of Holt–Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106(6):709–721View ArticlePubMedGoogle Scholar
  8. Gruenauer-Kloevekorn C, Froster UG (2003) Holt–Oram syndrome: a new mutation in the TBX5 gene in two unrelated families. Ann Genet 46:19–23View ArticlePubMedGoogle Scholar
  9. Harris LC, Osborne WP (1966) Congenital absence or hypoplasia of the radius with ventricular septal defect: ventriculo-radial dysplasia. J Pediatr 68:265–272View ArticleGoogle Scholar
  10. Holt M, Oram S (1960) Familial heart disease with skeletal malformation. Br Heart J 22:236–242View ArticlePubMedPubMed CentralGoogle Scholar
  11. Hoogaars WM, Engel A, Brons JF, Verkerk AO, de Lange FJ, Wong LY, Bakker ML, Cluot DE, Wakker V, Barnett P, Ravesllot JH, Moorman AF, Verheijck EE, Christoffels VM (2007) Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev 21:1098–1112View ArticlePubMedPubMed CentralGoogle Scholar
  12. Linden H, Williams R, King J, Blair E, Kini U (2009) Ulnar mammary syndrome and TBX3: expanding the phenotype. Am J Med Genet 149A:2809–2812View ArticlePubMedGoogle Scholar
  13. Lorenzen JA, Bonacci BB, Palmer RE, Wells C, Zhang J, Haber DA, Goldstein AM, Mayer AN (2005) Rbm19 is a nucleolar protein expressed in crypt/progenitor cells of the intestinal epithelium. Gene Expr Patterns 6(1):45–56View ArticlePubMedGoogle Scholar
  14. Newbury-Ecob RA, Leanage R, Raeburn JA, Young ID (1996) Holt–Oram syndrome: a clinical genetic study. J Med Genet 33:300–307View ArticlePubMedPubMed CentralGoogle Scholar
  15. Pallister PD, Herrmann J, Opitz JM (1976) A pleiotropic dominant mutation affecting skeletal, sexual and apocrine-mammary development. Birth Defect Orig Art Ser XII 5:247–254Google Scholar
  16. Schinzel A (1987) Ulnar-mammary syndrome. J Med Genet 24:778–781View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2016